2025
Research Articles
Copy Link
- Access to Information Cited in National Organization for Rare Disorders Reports (JAMA Network Open, 5/21/25)
- Insulin Rationing in States With and Without Insulin Copay Caps: A Cross-Sectional Study (Health Affairs Scholar, 5/08/25)
- Nonconcurrent Control Use in FDA Approval of High-Risk Medical Devices (JAMA Network Open, 4/22/25)
- Research Derived from Medicare’s Coverage with Evidence Development Program (JAMA Network Open, 4/15/25)
- FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022 (Journal of Law, Medicine & Ethics, 4/08/25)
- Shareholder Payouts Among Large Publicly Traded Health Care Companies (JAMA Internal Medicine, 2/10/25)
- Characterization of studies considered and required under Medicare’s coverage with evidence development program (Clinical Trials, 2/08/25)
- An App a Day will (Probably Not) Keep the Doctor Away: An Evidence Audit of Health and Medical Apps Available on the Apple App Store (Minds and Machines, 2/05/25)
Commentaries in Medical Journals
Copy Link
- Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries (The New England Journal of Medicine, 2/01/25)
Opinion Pieces in Lay Media
Copy Link
- A Court Decision on Lab-Developed Tests Sets a Dangerous Precedent (STAT News, 5/05/25)
- The Sudden Dismissal of Public Records Staff at Health Agencies Threatens Government Accountability (The Conversation, 4/16/25)
- Gutting FDA Won't Make America Healthy (MedPageToday, 3/04/25)
Public Comments
Copy Link
In the Media
Copy Link
- RFK Jr. Takes Aim at COVID Shots for Kids, Worrying Vaccine Experts, The Detroit News (5/08/25)
- The Science and Politics of Vaccines Collide, Yale Insights (5/06/25)
- The End of Compounded GLP-1 Copies Leaves Many Patients in a ‘Lose-Lose’ Position, STAT News (4/29/25)
- How Marty Makary’s FDA is Embracing a More Skeptical View of Vaccines, STAT News (4/29/25)
- Key FDA Drug Data Goes Missing Amid DOGE Cuts, Axios (4/24/25)
- US FDA’s Makary Floats Vague ‘Plausible Mechanism’ Approval Pathway For Rare Diseases, Pink Sheet (4/22/25)
- CDC Officials Plan for the Agency’s Splintering, but Questions Remain, Associated Press (4/10/25)
- Kennedy’s Moves on Measles Don’t Quell Criticism, The Hill (4/09/25)
- “Guaranteed Pandemonium” as HHS Secretary Slashes Federal Health Workforce, JAMA Medical News (4/05/25)
- Connecticut Sues Trump Administration Over $150M in Public Health Cuts, Yale Daily News (4/04/25)
- 5 High-Level CDC Officials are Leaving in the Latest Turmoil for the Public Health Agency, Pittsburgh Post-Gazette (3/25/25)
- F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts, The New York Times (3/06/25)
- Weight Loss Drugs May Become Harder to Get. What Does that Mean for Patients? WBUR (2/28/25)
- ANALYSIS: RFK Jr.’s Health Revolution: Reform or Risk? Yale Daily News (2/28/25)
- On Measles Outbreak, the Trump Administration’s Messaging Strikes Some as Off-Key, STAT News (2/27/25)
- RFK Jr. Readies Review of Childhood Vaccine Schedule after Pledging Not to, Endpoints News (2/19/25)
- Doctors for America Discusses Lawsuit Against Federal Agencies, WGN 720 Radio (2/17/25)
- Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs, Medscape (2/13/25)
- US FDA Advisory Committee Freeze Raises Concerns of Delayed, more Controversial Approvals, Pink Sheet (2/10/25)
- RFK Jr. says he's not anti-vaccine in Senate confirmation hearing, KCBS Radio (1/29/25)
- ‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs, STAT News (1/28/25)
- What will happen to Medicare drug pricing negotiations under Trump?, MM+M (1/24/25)
- Advocates Slam US-Gilead Patent Settlement Over HIV PrEP Drugs, Bloomberg Law News(1/21/25)
- Misleading Statements Common in Online Ads for Compounded GLP-1s, tctMD (1/20/25)
- Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks, STAT News (1/17/25)
- E-sellers of compounded weight-loss drugs fail to reveal risks, research shows Reuters (1/17/25)
- Despite New FDA Guidance, Doctors Say Accelerated Approval Process Still Flawed, MedCentral (1/16/25)
- Federal watchdog raises some concerns about the FDA’s accelerated approval program, STAT News(1/14/25)